OPTIMIZATION OF SCREENING FOR VAGINAL INFECTIONS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS
- Authors: Kira E.F.1, Semenova K.Y.2, Bobrova M.V.3, Belyakova A.A.3, Gasilova N.A.3
-
Affiliations:
- Institute for Postgraduate Training of Physicians, N.I. Pirogov National Medical and Surgical Center, Ministry of Health of Russia
- City Polyclinic Seventeen
- INVITRO LLC
- Issue: No 8 (2018)
- Pages: 167-173
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248383
- ID: 248383
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Eugene F. Kira
Institute for Postgraduate Training of Physicians, N.I. Pirogov National Medical and Surgical Center, Ministry of Health of Russia
Email: profkira33@gmail.com
honored scientist of the Russian Federation, honored Doctor of the Russian Federation, academician of RAS, MD, Professor, head of the Department of Women’s Diseases and Reproductive health of the lInstitute for Improvement of Physicians 105203, Russia, Moscow, Nizgnya Pervomayskaya str. 70
Ksenia Y. Semenova
City Polyclinic Seventeen
Email: semenovakl98l@mail.ru
Doctor obstetrician-gynecologist 195176, Russia, St. Petersburg, Metallistov str. 56
Maria V. Bobrova
INVITRO LLC
Email: mbobrova@invitro.ru
the head of the organizational-methodical Department of interaction with specialists of the healthcare sector l25047, Russia, Moscow, 4th Tverskaya-Yamskaya str. l6, bld. 3
Anna A. Belyakova
INVITRO LLC
Email: abelyakova@invitro.ru
candidate of medical sciences, Doctor of Clinical and Laboratory Diagnostics l25047, Russia, Moscow, 4th Tverskaya-Yamskaya str. l6, bld. 3
Natalia A. Gasilova
INVITRO LLC
Email: NGasilova@invitro.ru
Head of the Laboratory of Molecular Diagnostics l25047, Russia, Moscow, 4th Tverskaya-Yamskaya str. l6, bld. 3
References
- Суламанидзе Л.А., Назарова Н.М., Прилепская В.Н., Бурменская О.В., Демура Т.А., Гордеев С.С., Чупрынин В.Д., Трофимов Д.Ю. Результаты ВПЧ-генотипирования эпителия шейки матки и анальной области у пациенток с цервикальными интраэпителиальными неоплазиями. Гинекология. 2016; 18(1): 45-8.
- Костин А.А., Старинский В.В., Самсонов Ю.В., Асратов А.Т. Анализ статистических данных о злокачественных новообразованиях, ассоциированных с вирусом папилломы человека. Исследования и практика в медицине. 2016; 3(1): 66-78.
- Centers for Disease Control and Prevention. Prevalence and cost of sexually transmitted infections in the United States. February 2013.
- Andrae B., Kemetli L., Sparén P., Silfverdal L., Strander B., Ryd W., Dillner J., Törnberg S. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J. Natl.Cancer Inst. 2008; 100(9): 622-9.
- Oscarsson M.G., Benzein E.G., Wijma B.E. Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden. J. Psychosom. Obstet. Gynaecol. 2008; 29(1): 23-31.
- Sanner K., Wikström I., Strand A., Lindell M., Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br. J. Cancer. 2009; 101(5): 871-4.
- Артымук Н.В., Марочко К.В. Эффективность выявления вируса папилломы человека при помощи устройства для самостоятельного забора вагинального отделяемого. Акушерство и гинекология. 2016; 3: 85-91.
Supplementary files
![](/img/style/loading.gif)